Host Innate Immune Response to Mycobacterium tuberculosis
- 16 March 2007
- journal article
- review article
- Published by Springer Nature in Journal of Clinical Immunology
- Vol. 27 (4) , 347-362
- https://doi.org/10.1007/s10875-007-9084-0
Abstract
This review focuses on recent progress in our understanding of Mycobacterium tuberculosis survival in macrophages, the interaction of M. tuberculosis with Toll-like receptors (TLRs) and the establishment of the link between innate and adaptive immunity, and TLRs and interferon-γ-mediated antimicrobial pathways in macrophages. We also propose a paradigm that TLR2 signaling regulates the magnitude of the host Th1 response leading to either M. tuberculosis persistence and latent infection or replication and disease.Keywords
This publication has 178 references indexed in Scilit:
- Neutralization or Absence of the Interleukin-23 Pathway Does Not Compromise Immunity to Mycobacterial InfectionInfection and Immunity, 2006
- Variants in the SP110 gene are associated with genetic susceptibility to tuberculosis in West AfricaProceedings of the National Academy of Sciences, 2006
- Interleukin 12p40 is required for dendritic cell migration and T cell priming afterMycobacterium tuberculosisinfectionThe Journal of Experimental Medicine, 2006
- Impaired maturation and function of dendritic cells by mycobacteria through IL-1βEuropean Journal of Immunology, 2006
- Constitutive Differences in Gene Expression Profiles Parallel Genetic Patterns of Susceptibility to Tuberculosis in MiceInfection and Immunity, 2006
- Chemokine receptor 5 and its ligands in the immune response to murine tuberculosisTuberculosis, 2005
- Mycobacterium's Arrest of Phagosome Maturation in Macrophages Requires Rab5 Activity and Accessibility to IronMolecular Biology of the Cell, 2003
- Mycobacterium tuberculosisglycosylated phosphatidylinositol causes phagosome maturation arrestProceedings of the National Academy of Sciences, 2003
- Tuberculosis Associated with Infliximab, a Tumor Necrosis Factor α–Neutralizing AgentNew England Journal of Medicine, 2001
- A Prospective Study of the Risk of Tuberculosis among Intravenous Drug Users with Human Immunodeficiency Virus InfectionNew England Journal of Medicine, 1989